Amylyx Pharmaceuticals, Inc. AMLX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s total assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported total assets of $293.6M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s total assets increased by 33.7% year-over-year, from $219.68M to $293.6M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total assets?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s total assets has grown at a 33.2% compound annual growth rate (CAGR), from $105.61M to $332.65M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.